Literature DB >> 15178956

Prenatal screening and the reduction of birth defects in populations.

P A Baird1.   

Abstract

OBJECTIVES: Birth defects occur in populations in 3-5% of births. This paper assesses whether population-wide screening programmes for pregnant women would be likely to result in major decreases in the prevalence of birth defects.
METHOD: Relevant literature on this question is reviewed and synthesized.
RESULTS: Given certain assumptions, a decrease from 3-5 to 2-4% in the prevalence of defects at birth may be possible. The resources required to put in place an appropriately delivered programme to achieve this are substantial.
CONCLUSIONS: As well as the potential benefit of a decrease, there are opportunity costs, and potential serious harms. Unless undertaken in a carefully planned and monitored way, a population-based birth defects reduction programme is likely to bring harm and anxiety rather than benefit.

Entities:  

Year:  1999        PMID: 15178956     DOI: 10.1159/000016177

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  3 in total

1.  Prevalence and factors associated with congenital malformations in tirana, Albania, during 2011-2013.

Authors:  Dorina Canaku; Ervin Toçi; Enver Roshi; Genc Burazeri
Journal:  Mater Sociomed       Date:  2014-06-21

2.  Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing.

Authors:  Shengpei Chen; Huijuan Ge; Xuebin Wang; Xiaoyu Pan; Xiaotian Yao; Xuchao Li; Chunlei Zhang; Fang Chen; Fuman Jiang; Peipei Li; Hui Jiang; Hancheng Zheng; Lei Zhang; Lijian Zhao; Wei Wang; Songgang Li; Jun Wang; Jian Wang; Huanming Yang; Yingrui Li; Xiuqing Zhang
Journal:  Genome Med       Date:  2013-02-27       Impact factor: 11.117

3.  Exploring risk perception and attitudes to miscarriage and congenital anomaly in rural Western Kenya.

Authors:  Stephanie Dellicour; Meghna Desai; Linda Mason; Beatrice Odidi; George Aol; Penelope A Phillips-Howard; Kayla F Laserson; Feiko O Ter Kuile
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.